Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aeroscena is a healthcare company specializing in clinical aromatherapy, developing evidence-based phyto-inhalants designed for use in clinical and consumer settings. The company's primary product line, Ascents, utilizes proprietary formulas of essential oils to address common symptoms such as nausea, anxiety, and insomnia without the side effects of traditional pharmaceuticals. Aeroscena distinguishes itself by focusing on clinical validation, with its products being used in hospitals and healthcare systems to improve patient outcomes and satisfaction. Their delivery systems include personal inhalers and ambient diffusion technologies tailored for medical environments. The company collaborates with major medical institutions like the Cleveland Clinic to conduct research on the efficacy of scent-based interventions. By standardizing the delivery of volatile organic compounds from plants, Aeroscena aims to provide a reliable, non-pharmacological alternative for symptom management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aeroscena.